Skip to Main Content
MyYSM
YSM Home

INFORMATION FOR

YJBM's December 2024 Issue Focuses on Viruses and Autoimmunity

December 07, 2024
by Kate Woodford

YJBM 97:4 2024: Viruses and Autoimmunity

Stylized journal cover art featuring a human bust with exaggerated halftone dots, resembling an electron micrograph. A stream of antibodies winds through clusters of yellow-orange viruses, with the changing color reflecting the viruses’ influence. As the antibodies reach the human bust, they become red, which symbolizes the chaotic and dangerous autoimmune response.

Photo by Peter K. Harris

The December 2024 issue of the Yale Journal of Biology and Medicine (YJBM), on Viruses and Autoimmunity, will be published on December 19. This issue features articles on the myriad ways that viruses and the human autoimmune systems are being studied.

Highlights include an original contribution by Amaral, Schoen, Bingham, et al. (Federal University of Cariri, Brazil; Yale School of Medicine; Johns Hopkins School of Medicine) entitled “Correlation Between Pain, Disease Activity, and Rheumatoid Factor Positivity in Patients with Chikungunya Arthritis.” Chikungunya virus (CHIKV) is an acute viral disease that can develop into chronic illness—Amaral et al. analyzed the relationship between CHIKV pain and other variables to better understand the correlations that can help patient symptoms.

Next, the issue presents a case report by Nguyen et al. (Byers Eye Institute, Stanford University) entitled “Tocilizumab for Cystoid Macular Edema Secondary to Immune Recovery Uveitis in a Patient with Contraindications to Long-Term Systemic Corticosteroid.” Nguyen et al. describe a successful treatment with tocilizumab (TCZ) of a young patient with a previous history of cytomegalovirus (CMV) retinitis who presented with cystoid macular edema (CME).

Lastly, “The Intestine in Acute and Long COVID: Pathophysiological Insights and Key Lessons” is a review by Zollner et al. (Medical University of Innsbruck, Austria). Long COVID is a complex health condition affecting many organ systems in the human body. This review highlights studies that show how “gut” disruption plays a major role in the multifactorial symptoms that patients with Long COVID experience.

Deputy editors of this issue: RuthMabel Boytz (Department of Microbial Pathogenesis, Yale School of Medicine) and Evan Navori (Department of Epidemiology of Microbial Diseases, Yale School of Public Health).

YJBM editors-in-chief: Charlotte Godfrey (Molecular Biophysics & Biochemistry, Yale University) and Samantha Seneviratne (Yale School of Public Health).

The YJBM is open-access for all.

Tags